Company news

A recent study has shed light on the significant clinical application of fecal calprotectin testing in the field of colorectal cancer screening. Fecal calprotectin, a protein associated with intestinal inflammation, has proven to be a valuable biomarker for the early detection and monitoring of colorectal cancer.

What is C-reactive protein and why is it associated with fever and cough?

C-reactive protein (CRP) is an important biomarker that plays a crucial role in the immune response to inflammation in the body.

C-reactive protein (CRP) is a plasma protein and a nonspecific indicator of inflammatory response in the human body. The CRP detection kit is designed to assist doctors in diagnosing and monitoring the progression of inflammatory diseases by measuring the levels of CRP.

Hormone six-panel examination is a blood test that includes follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), progesterone (P), testosterone (T), and prolactin (PRL).

The human body usually has two kidneys, one on each side, shaped like broad beans, often described as the "source of life", responsible for filtering blood, removing waste, maintaining water and electrolyte balance, and ensuring the stability of the human internal environment.

Mycoplasma pneumoniae is a pathogenic microorganism between viruses and bacteria, it mainly causes respiratory infections, upper respiratory infections and acute bronchitis are the most common, about 5-10% will develop pneumonia, called mycoplasma pneumonia. Mycoplasma has no cell wall in its structure, so it is resistant to antibiotics such as penicillin and cephalosporin that target the cell wall.

The combined use of calprotectin and fecal occult blood screening for colorectal cancer has drawn a significant attention in recent years as a screening project. It is primarily used to detect early-stage colorectal cancer and polyps, in order to increase the chances of successful treatment.

In the early stages of colon cancer, patients may experience changes in stool shapes, abnormal bowel habits or hemafecia. Many people think that is just a common digestive problem, or mistaken for hemorrhoids, and fail to have examined and treated in time.

After the age of 50, the risk of colorectal tumors begins to rise, thus it is not difficult to understand that the over 50 age group is the “key focus group” of colorectal cancer. However, in recent years, it has been founded that the incidence of colorectal cancer among young people is gradually increasing.